Article
Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma.
Allergy and asthma proceedings - 27 Sept 2022
Khan Najm S, Rubin Elizabeth, McKenna Bernard, Palowitch Bernard L, Sonnenberg Frank, Argon Judith, Panettieri Reynold A
Abstract excerpt
Background: Biomarker measurements improve the phenotyping of patients with severe uncontrolled asthma (SUA) and predict therapeutic responses. The use of biomarkers in asthma, however, remains underused. Objective: To test the hypothesis that biomarker measurements of patients with SUA remain markedly underused and contributes to asthma morbidity and oral corticosteroid use. Methods: Leveraging claims data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.